Last week, we posted a segment from a Boston television station about insurers offering payments to docs for switching a patient from a brand-name to a generic, particularly from Lipitor to a generic Zocor. There's nothing new about managed care offering incentives to docs to lower costs and improve health outcomes. But we asked you whether docs should disclose payments and take our poll. We received 75 responses. Although unscientific, the results suggest that docs should think hard about this topic.
Yes - 64 votes, or 85 percent, say docs should disclose the payments;
No - 11 votes, or 15 percent.
To watch the segment, in case you missed it, please click here.